Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The adult muscle-type nicotinic acetylcholine receptor (nAChR) is a pentameric ligand-gated ion channel located at the postsynaptic membrane of the neuromuscular junction (StatPearls, 2023). It is specifically characterized by its subunit composition of two alpha-1, one beta-1, one delta, and one epsilon subunit, which replaces the gamma subunit found in the fetal isoform (UniProt, 2024). When the neurotransmitter acetylcholine binds to the alpha subunits, the receptor channel opens to allow the influx of sodium and calcium ions, resulting in membrane depolarization and muscle fiber contraction (PubMed, 2012). This receptor is the primary target for neuromuscular blocking agents used in clinical anesthesia to facilitate endotracheal intubation and provide muscle relaxation during surgical procedures (StatPearls, 2023). In autoimmune conditions like Myasthenia gravis, the receptor is targeted by pathogenic antibodies, leading to its degradation and impaired neuromuscular transmission (NIH, 2023). Understanding its structure and function is critical for managing neuromuscular disorders and optimizing the use of muscle relaxants in perioperative care.
Competitive antagonism of acetylcholine binding sites (non-depolarizing blockade) or persistent activation leading to receptor desensitization (depolarizing blockade).
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adult muscle-type nicotinic acetylcholine receptor (nAChR) (nAChR).